Immune therapy in inflammatory bowel disease and models of colitis
- 1 December 2001
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 88 (12) , 1558-1569
- https://doi.org/10.1046/j.0007-1323.2001.01909.x
Abstract
Background: A proliferation of animal models has not only improved our understanding of inflammatory bowel disease, it has also formed the basis of new treatment strategies. Methods: A search was conducted using the National Library of Medicine for articles discussing immune therapies for inflammatory bowel disease. This was supplemented by findings from the authors' own laboratory. Results: An overview of the different animal models is presented. These models are used to highlight the recent human trials of immune therapies. Potential future therapies are also discussed. Conclusion: Immune therapies have altered the management of patients with inflammatory bowel disease. In future they will influence not only the indications for surgery but also its timing and outcome.Keywords
This publication has 109 references indexed in Scilit:
- Regulatory T Cells in AutoimmmunityAnnual Review of Immunology, 2000
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich ElementsImmunity, 1999
- Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitisPublished by Elsevier ,1999
- Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strainGut, 1998
- Altered Immune Responses in Interleukin 10 Transgenic MiceThe Journal of Experimental Medicine, 1997
- Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion.The Journal of Experimental Medicine, 1996
- Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cellsPublished by Elsevier ,1994
- Published by American Association for the Advancement of Science (AAAS) ,1994
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992